GlobeNewswire Inc.··Mordor IntelligenceCancer Biomarkers Market Poised for 51% Growth Through 2031 as Precision Oncology Gains Ground
Cancer biomarkers market projected to grow from $23.22B (2026) to $35.16B (2031) at 8.65% CAGR, driven by precision oncology adoption and early detection demand.
ILMNRHHBYTMOBIOBIO.B+1personalized medicinecompanion diagnostics